The augmentation of in vitro and in vivo tumor-specific T cell-mediated immunity by amplifier T lymphocytes. 1980

H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007942 Leukemia, Experimental Leukemia induced experimentally in animals by exposure to leukemogenic agents, such as VIRUSES; RADIATION; or by TRANSPLANTATION of leukemic tissues. Experimental Leukemia,Experimental Leukemias,Leukemia Model, Animal,Leukemias, Experimental,Animal Leukemia Model,Animal Leukemia Models,Leukemia Models, Animal
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D010954 Plasmacytoma Any discrete, presumably solitary, mass of neoplastic PLASMA CELLS either in BONE MARROW or various extramedullary sites. Plasma Cell Tumor,Plasmocytoma,Plasma Cell Tumors,Plasmacytomas,Plasmocytomas,Tumor, Plasma Cell,Tumors, Plasma Cell
D002471 Cell Transformation, Neoplastic Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill. Neoplastic Transformation, Cell,Neoplastic Cell Transformation,Transformation, Neoplastic Cell,Tumorigenic Transformation,Cell Neoplastic Transformation,Cell Neoplastic Transformations,Cell Transformations, Neoplastic,Neoplastic Cell Transformations,Neoplastic Transformations, Cell,Transformation, Cell Neoplastic,Transformation, Tumorigenic,Transformations, Cell Neoplastic,Transformations, Neoplastic Cell,Transformations, Tumorigenic,Tumorigenic Transformations
D003602 Cytotoxicity, Immunologic The phenomenon of target cell destruction by immunologically active effector cells. It may be brought about directly by sensitized T-lymphocytes or by lymphoid or myeloid "killer" cells, or it may be mediated by cytotoxic antibody, cytotoxic factor released by lymphoid cells, or complement. Tumoricidal Activity, Immunologic,Immunologic Cytotoxicity,Immunologic Tumoricidal Activities,Immunologic Tumoricidal Activity,Tumoricidal Activities, Immunologic
D005260 Female Females
D006649 Histocompatibility Antigens A group of antigens that includes both the major and minor histocompatibility antigens. The former are genetically determined by the major histocompatibility complex. They determine tissue type for transplantation and cause allograft rejections. The latter are systems of allelic alloantigens that can cause weak transplant rejection. Transplantation Antigens,Antigens, Transplantation,Histocompatibility Antigen,LD Antigens,SD Antigens,Antigen, Histocompatibility,Antigens, Histocompatibility,Antigens, LD,Antigens, SD
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry
March 1985, Gan to kagaku ryoho. Cancer & chemotherapy,
H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry
August 1973, European journal of immunology,
H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry
September 1972, Journal of the National Cancer Institute,
H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry
June 1993, Journal of immunology (Baltimore, Md. : 1950),
H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry
July 1999, The New England journal of medicine,
H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry
June 1983, Journal of immunology (Baltimore, Md. : 1950),
H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry
April 1994, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy,
H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry
January 1998, Advances in immunology,
H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry
April 1987, The Japanese journal of experimental medicine,
H Fujiwara, and T Hamaoka, and G M Shearer, and H Yamamoto, and W D Terry
October 1977, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!